Wednesday, 14 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 6, 2025

Labrador Gold Provides Update on Exploration at the Hopedale and Borden Lake Extension Gold Projects

View original at globenewswire.com
Labrador Gold Provides Update on Exploration at the Hopedale and Borden Lake Extension Gold Projects TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The results of the 2025 exploration program will be integrated with previous work over the course of the winter to determine follow up work for the 2026 season

    80% confidence

  • Labrador Gold continues to actively evaluate opportunities within the resource space with a particular focus on Canada

    80% confidence

  • The high chargeability anomaly on the eastern side of the IP grid is believed to be formational and related to disseminated pyrite in metasedimentary rocks

    80% confidence

  • Since launching project acquisition initiative, LabGold team has reviewed 29 resource projects and another 22 pre-resource projects have been assessed for their potential to host a significant resource

    80% confidence

  • The Hopedale property covers much of the Archean-age Florence Lake greenstone belt that stretches over 60 km and is prospective for orogenic gold, volcanogenic massive sulphide (VMS) and magmatic copper-nickel deposits

    80% confidence

  • The Company identified several projects for extensive due diligence as part of its growth strategy

    80% confidence

  • No obvious mineralization was encountered during the BLE bedrock sampling program

    80% confidence

  • The high chargeability of this unit may be masking the chargeability of the gold mineralized trends to some extent

    80% confidence

  • The IP survey defined a trend of moderate chargeability coincident with high resistivity that links the significant gold occurrences

    80% confidence

  • The Borden Lake Extension property occurs in the Kapuskasing Structural Zone and is contiguous with Discovery's Borden Gold Mine property

    80% confidence

  • The aim of the drone magnetic and LiDAR survey was to better define the contact between felsic gneisses to the south, and mafic gneiss and amphibolite units to the north which are interpreted to be part of the Borden Mine sequence stratigraphy

    80% confidence

  • The Company will await assay results before deciding on next steps for the BLE project

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com